Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 5/20 | 0.59 |
| ▸ | MAGI3 | Q5TCQ9 | 1/20 | 0.58 |
| ▸ | CASP1 | P29466 | 1/20 | 0.56 |
| ▸ | CASP3 | P42574 | 1/20 | 0.56 |
| ▸ | CASP4 | P49662 | 1/20 | 0.56 |
| ▸ | CASP5 | P51878 | 1/20 | 0.56 |
| ▸ | CASP7 | P55210 | 1/20 | 0.56 |
| ▸ | CASP9 | P55211 | 1/20 | 0.56 |
| ▸ | CASP6 | P55212 | 1/20 | 0.56 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.56 |
| ▸ | CASP10 | Q92851 | 1/20 | 0.56 |
| ▸ | KISS1R | Q969F8 | 3/20 | 0.55 |
| ▸ | IL23R | Q5VWK5 | 7/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Kqikiwfqnkkmkwkk-Nh2 SCHEMBL31748869 | 0.86 | PTH1R (0.60) | GHSRIL23R | |
| SCHEMBL1271579 | 0.86 | MAGI3 (0.60) | GHSRMAGI3CASP1CASP3CASP4 | |
| SCHEMBL29433937 | 0.85 | KISS1R (0.61) | GHSRMAGI3KISS1RIL23R | |
| SCHEMBL27913477 | 0.84 | EDNRA (0.59) | KISS1R | |
| SCHEMBL27913484 | 0.84 | EDNRA (0.59) | KISS1R | |
| SCHEMBL29555584 | 0.83 | KISS1R (0.67) | KISS1RIL23R | |
| SCHEMBL29850431 | 0.83 | GLP1R (0.64) | KISS1R | |
| SCHEMBL30378939 | 0.83 | PTH1R (0.60) | GHSRMAGI3KISS1RIL23R | |
| SCHEMBL1373223 | 0.83 | KISS1R (0.61) | GHSRKISS1RIL23R | |
| SCHEMBL1373215 | 0.83 | KISS1R (0.61) | GHSRKISS1RIL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230173084-A1 | PEPTIDE-BASED SYNTHETIC CHLORIDE ION TRANSPORTERS | TAVANTA THERAPEUTICS HUNGARY INCORPORATED (HU) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230173084-A1 | PEPTIDE-BASED SYNTHETIC CHLORIDE ION TRANSPORTERS | CFTR, SLC26A3, SLC26A4 | GHSR 989/4885MAGI3 2874/4885CASP1 3934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.